BioSpace News Archive

Press Releases

Ocugen Clinical Showcase Highlighting Progress in Retinal Gene Therapy Clinical Trials in New York City on Tuesday, November 12, 2024

October 28, 2024
·
4 min read
Press Releases

Amicus Therapeutics to Announce Third Quarter 2024 Financial Results on November 6, 2024

October 28, 2024
·
1 min read
Press Releases

Evoke Pharma & EVERSANA Announce Statistically Significant Improvement in Patient Outcomes for GLP-1 users with Diabetic Gastroparesis using GIMOTI®

October 28, 2024
·
12 min read
Press Releases

PROCEPT BioRobotics® Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue and Adjusted EBITDA Guidance

October 28, 2024
·
11 min read
Press Releases

T-Neuro Pharma to Presents Expanded Alzheimer’s Disease Blood Biomarker Assay at Clinical Trials on Alzheimer’s Disease (CTAD) conference

October 28, 2024
·
2 min read
Press Releases

Eupraxia Pharmaceuticals to Present at American College of Gastroenterology Annual Scientific Meeting 2024

October 28, 2024
·
7 min read
Press Releases

Parabilis Medicines™ – Formerly FogPharma – Announces New Company Name and Unveils AI- and Physics-Based Discovery Platform

October 28, 2024
·
3 min read
Press Releases

Delta-Fly Pharma Inc.: Phase I/II Study of DFP-10917 and Venetoclax in AML Patients Begins with Promising Initial Data

October 28, 2024
·
1 min read
Press Releases

BPGbio CEO Niven R. Narain to Present at Google’s Inaugural Cancer AI Symposium

October 28, 2024
·
3 min read
Press Releases

Merck and Moderna Initiate Phase 3 Trial Evaluating Adjuvant V940 (mRNA-4157) in Combination with KEYTRUDA® (pembrolizumab) After Neoadjuvant KEYTRUDA and Chemotherapy in Patients With Certain Types of Non-Small Cell Lung Cancer (NSCLC)

October 28, 2024
·
19 min read